Do family physicians fail to provide triptans for patients with migraine?

Journal of Family Practice

Volumn 55, Issue 12, 2006, Pages 1057-1062

  Walling, Anne ^a,b   Woolley, Douglas C ^a,b   Molgaard, Craig ^a,b   Kallail, K James ^a,b  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE WICHITA   (United States)

^b Department of Family and Community Medicine ^*

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; ERGOT DERIVATIVE; ERGOTAMINE DERIVATIVE; NARCOTIC AGENT; TRIPTAN DERIVATIVE;

ADULT; AGED; ARTICLE; DRUG COST; DRUG INDICATION; DRUG WITHDRAWAL; FEMALE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MALE; MIGRAINE; PATIENT SATISFACTION; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; QUESTIONNAIRE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ATTITUDE TO HEALTH; CONTINUITY OF PATIENT CARE; FAMILY PRACTICE; FEMALE; HUMANS; KANSAS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; PATIENT SATISFACTION; PHYSICIAN'S PRACTICE PATTERNS; PHYSICIAN'S ROLE; PRIMARY HEALTH CARE; QUESTIONNAIRES; SEROTONIN AGONISTS; TREATMENT REFUSAL;

EID: 33845654490     PISSN: 00943509     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Nutting PA, Baier M, Werner JJ, Cutter G, Reed FM, Orzano AJ, Practice patterns of family physicians in practice-based research networks: a report from ASPN. J Am Board Fam Pract 1999; 12:278-284.
2. Gibbs TS, Fleischer AB, Feldman SR, Sam MC, O'Donovan CA. Health care utilization in patients with migraine: demographics and patterns of care in the ambulatory setting. Headache 2003; 43:330-335.
3. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American migraine study II. Headache 2001:41:646-657.
4. Lipton RB, Scher AI, Kolodner K, Liberman J, Steiner TJ, Stewart WF. Migraine in the United States: Epidemiology and patterns of health care use. Neurology 2002; 58:885-894.
5. Lipton RB, Diamond S, Reed M, Diamond M, Stewart WF. Migraine diagnosis and treatment: results from the American Migraine Study II. Headache 2001; 41:638-645.
6. Wlaizels M. Model interventions to improve headache outcomes in health care systems. In Reducing the Burden of Headache, Olesen J, Steiner TJ, Lipton RB (eds). New York: Oxford University Press; 2003:290-301.
7. Bigal ME, Kolodner KB, Lafata JE, Leotta C, Lipton RB. Patterns of medical diagnosis and treatment of migraine and probable migraine in a health plan. Cephalalgia 2006; 26:43-49.
8. Cady R, Dodrick DW. Diagnosis and treatment of migraine. Mayo Clin Proc 2002; 77:255-261.
9. Lipton RB, Scher AI, Steiner TJ, et al. Patterns of health care utilization for migraine in England and in the United States. Neurology 2003; 60:441-448.
10. Loder EW, Lipton RB. Conclusion: how primary care physicians can help their patients with migraine. Am J Med 2005; 118:45S-46S.
11. Loder EW, Sheftell F. The quality of headache treatment in the United States: review and analysis of recent data. Headache 2005; 45:939-946.
12. Snow V, Weiss K, Wall EM, Mottur-Pilson C. Pharmacologic management of acute attacks of migraine and prevention of migraine headache. Ann Intern Med 2002; 137:840-849.
13. Lipton RB, Cutrer FM, Goadsby PJ, et al. How treatment priorities influence triptan preferences in clinical practice: perspectives of migraine sufferers, neurologists, and primary care physicians. Curr Med Res Opin 2005; 21:413-424.
14. Gallagher RM, Cutrer FM. Migraine: diagnosis, management, and new treatment options. Am J Man Care 2002; 8:S58-S73.
15. Silberstein SD. Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review). Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000; 55:754-763.
16. Ferrari MD, Roon KI, Lipton RB, Goadsby PJ. Oral triptans (setotonin 5-HT1B/1D agonists) in acute migraine treatment: a meta-analysis of 53 trials. Lancet 2001; 358:1668-1675.
17. Lohman JJHM, van der Kuy-de Ree MM. Patterns of specific antimigraine drug use-a study based on the records of 18 community pharmacies. Cephalalgia 2004; 25:214-218.
18. Von Korff M, Black LK, Saunders K, Galer BS. Headache medication-use among primary care headache patients in a health maintenance organization. Cephalalgia 1999; 19:575-580.
19. Available at: www.pozen.com/product/migraine.asp-pjbpubs.comi/ script_reports/migraine.htm.
20. Tepper SJ, Dahlof CG, Dowson A, et al. Prevalence and diagnosis of migraine in patients consulting their physician with a complaint of a headache: data from the Landmark Study. Headache 2004; 44:856-864.
21. Stewart WF, Lipton RB, Kolodner K, Liberman J, Sawyer J. Reliability of the migraine disability assessment score in a population-based sample of headache sufferers. Cephalalgia 1000; 19:107-114.
22. Stewart WF, Lipton RB, Kolodner KB, Sawyer J, Lee C, Liberman JN. Validity of the Migraine Disability Assessment Score in (MIDAS) n comparison to a diary-based measure in a population sample of migraine sufferers. Pain 2000; 88:41-52.
23. Andrasik F, Lipchik GL, McCroy DC, Wittrock DA. Outcome measurement in behavioral headache research: headache parameters and psychosocial outcomes. Headache 2005; 45:429-437.
24. Welch KMS, Mathew NT, Rosamond W, et al. Tolerability of sumatriptan: clinical trials and post-marketing experience. Cephalalgia 2000;20:687-695.
25. Robbins L. Triptans versus analgesics. Headache 2002; 42:903-907.
26. Savini N, Martin A, Browning D. Switching patients with migraine from sumatriptan to other triptans increases primary care costs. Int J Clin Prac 2004; 58:758-763.
27. Visser WH, de Vriend RHM, Jaspers NMWH, Ferrari MD. Sumatriptan in clinical practice: a 2-year review of 453 migraine patients. Neurology 1996; 47:46-51.
28. Powers C, Szeto S, Pangtay D, Bort T, Cervi M, Cady R. Evaluation of migraineurs' preferences for naratriptan over conventional first-line agents. Arch Fam Med 2000; 9:753-757
29. Boardman HF. Headaches in primary care: a pilot study. Cephalalgia 2000; 20:364.
30. Edwards P, Roberts I, Clarke M, et al. Increasing response rates to postal questionnaires: systematic review. BMJ 2002; 324:1183-1193.
31. Chao J, Gillanders WG, Flocke SA, et al. Billing for physician services: a comparison of actual billing with CPT codes assigned by direct observation. J Fam Pract 1998; 47:28-32.
32. Stange KC, Zyzanski SJ, Smith TF, et al. How valid are medical records and patient questionnaires for physician profiling and health services research? A comparison of direct observation of patients visits. Med Care 1998; 36:851-857
33. Headache Classification Subcommittee of the International Headache Society. The international classification of headache disorders 2nd ed. Cephalalgia 2004; 24:S1-S150.
34. Scott A, Smith RD. Keeping the customer satisfied: issues in the interpretation and use of patient satisfaction surveys. Int J Qual Health Care 1994; 6:353-359.
35. Linet MS, Celentano DC, Stewart WF. Headache characteristics associated with physician consultation: a population-based survey. Am J Prevent Med 1991; 7:40-46.
36. Lafata JE, Moon C, Leotta C, Kolodner K, Poisson L, Lipton RB. The medical care utilization and costs associated with migraine headache. J Gen Intern Med 2004; 19:1005-1012.